Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.

Knisely, Anne; Ahmed, Jibran; Stephen, Bettzy; Piha-Paul, Sarina A; Karp, Daniel; Zarifa, Abdulrazzak; Fu, Siqing; Hong, David Sanghyun; Rodon Ahnert, Jordi; Yap, Timothy A; Tsimberidou, Apostolia M; Alshawa, Anas; Dumbrava, Ecaterina E; Yang, Yali; Song, Juhee; Meric-Bernstam, Funda; Jazaeri, Amir A; Naing, Aung.

Cancer ; 130(3): 400-409, 2024 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-37864520

2.

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.

Altan, Mehmet; Tu, Janet; Milton, Denái R; Yilmaz, Bulent; Tian, Yanyan; Fossella, Frank V; Mott, Frank E; Blumenschein, George R; Stephen, Bettzy; Karp, Daniel D; Meric-Bernstam, Funda; Heymach, John V; Naing, Aung.

Cancer ; 129(17): 2685-2693, 2023 09 01.

Artículo en Inglés | MEDLINE | ID: mdl-37129197

3.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

Nardo, Mirella; Yilmaz, Bulent; Nelson, Blessie Elizabeth; Torres, Harrys A; Wang, Lan Sun; Granwehr, Bruno Palma; Song, Juhee; Dalla Pria, Hanna R F; Trinh, Van A; Glitza Oliva, Isabella C; Patel, Sapna P; Tannir, Nizar M; Kaseb, Ahmed Omar; Altan, Mehmet; Lee, Sunyoung S; Miller, Ethan; Zhang, Hao; Stephen, Bettzy A; Naing, Aung.

Oncologist ; 28(8): 714-721, 2023 08 03.

Artículo en Inglés | MEDLINE | ID: mdl-36952233

4.

Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.

Ravi, Vinod; Subramaniam, Aparna; Zheng, Jing; Amini, Behrang; Trinh, Van A; Joseph, Jocelyn; Mennel, Robert G; Bishop, Andrew J; Sturgis, Erich M; Goepfert, Ryan P; Yalamanchili, Sudha; Botello, Gilberto; Stephen, Bettzy; Piha-Paul, Sarina A; Patel, Anisha B; Lazar, Alexander J; Conley, Anthony P; Benjamin, Robert S; Patel, Shreyaskumar R; Futreal, Phillip A; Somaiah, Neeta; Naing, Aung.

Cancer ; 128(18): 3383-3391, 2022 09 15.

Artículo en Inglés | MEDLINE | ID: mdl-35792683

5.

Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.

Thein, Kyaw Z; Karp, Daniel D; Tsimberidou, Apostolia; Gong, Jing; Sulovic, Selma; Shah, Jatin; Milton, Denái R; Hong, David S; Janku, Filip; McQuinn, Lacey; Stephen, Bettzy A; Colen, Rivka; Carter, Brett W; Yap, Timothy A; Piha-Paul, Sarina A; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung.

Invest New Drugs ; 40(2): 290-299, 2022 04.

Artículo en Inglés | MEDLINE | ID: mdl-34562230

6.

Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial.

Hahn, Andrew W; Chahoud, Jad; Campbell, Matthew T; Karp, Daniel D; Wang, Jennifer; Stephen, Bettzy; Tu, Shi-Ming; Pettaway, Curtis A; Naing, Aung.

Invest New Drugs ; 39(5): 1405-1410, 2021 10.

Artículo en Inglés | MEDLINE | ID: mdl-33770291

7.

Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.

Alshawa, Anas; Cadena, Alexandra Perez; Stephen, Bettzy; Reddy, Akhila; Mendoza, Tito R; McQuinn, Lacey; Lawhorn, Kristie; Zarifa, Abdulrazzak; Bernhardt, Alexander Maximilian; Fessaheye, Senait; Warneke, Carla L; Chang, Joe Y; Naing, Aung.

Invest New Drugs ; 39(4): 1113-1122, 2021 08.

Artículo en Inglés | MEDLINE | ID: mdl-33580845

8.

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.

How, Jeffrey A; Jazaeri, Amir; Westin, Shannon N; Sood, Anil K; Ramondetta, Lois M; Xu, Mingxuan; Abonofal, Abdulrahman; Karp, Daniel D; Subbiah, Vivek; Stephen, Bettzy; Rodon, Jordi A; Yang, Fei; Naing, Aung.

Invest New Drugs ; 39(3): 829-835, 2021 06.

Artículo en Inglés | MEDLINE | ID: mdl-33415580

9.

Immune System in Action.

Stephen, Bettzy; Hajjar, Joud.

Adv Exp Med Biol ; 1342: 1-43, 2021.

Artículo en Inglés | MEDLINE | ID: mdl-34972961

10.

Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors.

Creasy, Caitlin A; Forget, Marie-Andrée; Singh, Gopal; Tapia, Coya; Xu, Mingxuan; Stephen, Bettzy; Sabir, Sharjeel; Meric-Bernstam, Funda; Haymaker, Cara; Bernatchez, Chantale; Naing, Aung.

Eur J Immunol ; 49(12): 2245-2251, 2019 12.

Artículo en Inglés | MEDLINE | ID: mdl-31532833

11.

Overview of Basic Immunology and Clinical Application.

Stephen, Bettzy; Hajjar, Joud.

Adv Exp Med Biol ; 1244: 1-36, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-32301008

12.

Radiomics to predict immunotherapy-induced pneumonitis: proof of concept.

Colen, Rivka R; Fujii, Takeo; Bilen, Mehmet Asim; Kotrotsou, Aikaterini; Abrol, Srishti; Hess, Kenneth R; Hajjar, Joud; Suarez-Almazor, Maria E; Alshawa, Anas; Hong, David S; Giniebra-Camejo, Dunia; Stephen, Bettzy; Subbiah, Vivek; Sheshadri, Ajay; Mendoza, Tito; Fu, Siqing; Sharma, Padmanee; Meric-Bernstam, Funda; Naing, Aung.

Invest New Drugs ; 36(4): 601-607, 2018 08.

Artículo en Inglés | MEDLINE | ID: mdl-29075985

13.

Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience.

Fujii, Takeo; Colen, Rivka R; Bilen, Mehmet Asim; Hess, Kenneth R; Hajjar, Joud; Suarez-Almazor, Maria E; Alshawa, Anas; Hong, David S; Tsimberidou, Apostolia; Janku, Filip; Gong, Jing; Stephen, Bettzy; Subbiah, Vivek; Piha-Paul, Sarina A; Fu, Siqing; Sharma, Padmanee; Mendoza, Tito; Patel, Anisha; Thirumurthi, Selvi; Sheshadri, Ajay; Meric-Bernstam, Funda; Naing, Aung.

Invest New Drugs ; 36(4): 638-646, 2018 08.

Artículo en Inglés | MEDLINE | ID: mdl-29159766

14.

Overview of Basic Immunology and Translational Relevance for Clinical Investigators.

Stephen, Bettzy; Hajjar, Joud.

Adv Exp Med Biol ; 995: 1-41, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-30539504

15.

Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.

Bupathi, Manojkumar; Hajjar, Joud; Bean, Stacie; Fu, Siqing; Hong, David; Karp, Daniel; Stephen, Bettzy; Hess, Kenneth; Meric-Bernstam, Funda; Naing, Aung.

Invest New Drugs ; 35(1): 59-67, 2017 02.

Artículo en Inglés | MEDLINE | ID: mdl-27687047

16.

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a singlecenter, multiarm phase Ib study.

Thein, Kyaw Z; Karp, Daniel D; Tsimberidou, Apostolia; Gong, Jing; Sulovic, Selma; Shah, Jatin; Milton, Denái R; Hong, David S; Janku, Filip; McQuinn, Lacey; Stephen, Bettzy A; Colen, Rivka; Carter, Brett W; Yap, Timothy A; Piha-Paul, Sarina A; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung.

Invest New Drugs ; 40(2): 463, 2022 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-34731355

17.

Overview of Basic Immunology for Clinical Investigators.

Stephen, Bettzy; Hajjar, Joud.

Adv Exp Med Biol ; 995: 1-31, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28321810

18.

Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.

Rodrigues, Heloisa Veasey; Ke, Danxia; Lim, JoAnn; Stephen, Bettzy; Bellido, Jorge; Janku, Filip; Zinner, Ralph; Tsimberidou, Apostolia; Hong, David; Piha-Paul, Sarina; Fu, Siqing; Naing, Aung; Subbiah, Vivek; Karp, Daniel; Falchook, Gerald; Kurzrock, Razelle; Wheler, Jennifer.

Invest New Drugs ; 33(3): 700-9, 2015 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-25902899

19.

Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies.

Hein, Kyaw Z; Stephen, Bettzy; Fu, Siqing.

J Immunother Precis Oncol ; 7(1): 41-52, 2024 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-38327752

20.

Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.

Guven, Deniz Can; Stephen, Bettzy; Sahin, Taha Koray; Cakir, Ibrahim Yahya; Aksoy, Sercan.

Laryngoscope ; 134(1): 7-17, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37227161

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.

Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.

Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial.

Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.

Immune System in Action.

Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors.

Overview of Basic Immunology and Clinical Application.

Radiomics to predict immunotherapy-induced pneumonitis: proof of concept.

Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience.

Overview of Basic Immunology and Translational Relevance for Clinical Investigators.

Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a singlecenter, multiarm phase Ib study.

Overview of Basic Immunology for Clinical Investigators.

Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.

Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies.

Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.